Objectives: To evaluate the effectiveness of a trachoma control program in a remote community before and after major environmental health improvements.
Design: Before-and-after cross-sectional design. The control program was in three rounds — each consisting of community census, screening of children < 13 years, health promotion activities and antibiotic treatment. There were two housing and infrastructure surveys.
Interventions: Treatment of affected children and their households with azithromycin at baseline, 7 and 21 months, and health promotions. Housing and sewerage infrastructure improvements were completed at 12 months.
Setting: Large, remote Central Australian Aboriginal community, 1998–2000.
Participants: All community residents.
Main outcome measures: Prevalence of active trachoma among children under 13 years; community population changes; and adequacy of housing facilities for healthy living practices.
Results: The prevalence of trachoma among children was 40% (95% CI, 32%–46%) at baseline, 33% (95% CI, 26%–40%) at 7 months' follow-up and 37% (95% CI, 29%–46%) at 21 months. These proportions were neither clinically nor statistically significantly different. There was a high degree of population mobility over the study period, with only 32% of residents appearing in all three censuses. The proportion of houses with completely adequate facilities increased from 0 to 16%.
Conclusions: Population mobility (both within and between communities), inadequate housing and continued crowding (despite improvements), as well as uncertainty about compliance with antibiotic treatment, are the likely factors contributing to the lack of effect of this trachoma control program. Because of high population mobility, a region-wide approach is needed for effective trachoma control.
- 1. National Trachoma and Eye Health Program. Sydney: Royal Australian College of Ophthalmologists, 1980.
- 2. Taylor HR. Eye health in Aboriginal and Torres Strait Islander communities. Uwankuru palya ngalkalpai — better vision for all. Canberra: Commonwealth Department of Health and Family Services, 1997.
- 3. Marx R. Social factors and trachoma: a review of the literature. Soc Sci Med 1989; 29: 23-29.
- 4. Pruss A, Mariotto SP. Preventing trachoma through environmental sanitation: a review of the evidence base. Bull World Health Organ 2000; 78(2): 258.
- 5. Congdon N, West S, Vitale S, et al. Exposure to children and risk of active trachoma in Tanzanian women. Am J Epidemiol 1993; 137: 366-372.
- 6. World Health Organization. Program for the Prevention of Blindness and Deafness. Future approaches to trachoma control. Report of a global scientific meeting, Geneva 1996. Geneva: WHO, 1997.
- 7. Laming A, Difrancesco M, Dixon B, et al. Trachoma six months after the first azithromycin program in Australia. Northern Territory Commun Dis Bull 1995; 2(7): 1.
- 8. Wallace T. Trachoma treatment program in the Katherine region. Northern Territory Commun Dis Bull 1996; 3(4): 13-15.
- 9. Meredith SJ, Peach HG, Devanesen D. Trachoma in the Northern Territory of Australia, 1940–1986. Med J Aust 1989;151: 190-196.
- 10. Lansingh VC, Weih LM, Keeffe JE, Taylor HR. Assessment of trachoma prevalence in a remote mobile population in Central Australia. Ophthalmic Epidemiol 2001; 8: 97-108.
- 11. Stocks N, Newland H, Hille J. The epidemiology of blindness and trachoma in the Anangu Pitjantjatjara of South Australia. Med J Aust 1994; 160: 751-756.
- 12. Ewald D, Hall G. Housing and health: An evaluation of the health impacts of the National Aboriginal Health Strategy – Environmental Health Program in one Central Australian community. Report for Collaborative Research Centre for Aboriginal and Tropical Health, 2001. Darwin: Collaborative Research Centre for Aboriginal and Tropical Health. In press.
- 13. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987; 65: 477-483.
- 14. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999; 354: 630-635.
- 15. Dawson CR, Schachter J, Sallam S, et al. A comparrison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis 1997; 24: 363-368.
- 16. Baily RL, Arullendran P, Whittle HC, Mabey DCW. Randomised controlled trial of single dose azithromycin in treatment of trachoma. Lancet 1993; 342: 543-546.
- 17. Commonwealth Department of Health and Aged Care National Indigenous housing guide. Canberra: The Department, 1999.
- 18. SPSS (Statistical Package for the Social Sciences) [computer program], version 9. Chicago, Ill: SPSS Inc, 1998.
- 19. Epi Info [computer program], version 6.14: A word processing, database and statistics program for epidemiology on microcomputers. Atlanta, Ga: Centres for Disease Control and Prevention, 1994.
- 20. Leitman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nature Medicine 1999; 5: 572-576.
- 21. Australian Bureau of Statistics. The health and welfare of Australia's Aboriginal and Torres Strait Islander Peoples. Canberra: ABS, 2001. (Catalogue No. 4704.0.)
- 22. Australian Bureau of Statistics. 1996 Census of population and housing. Selected family and labour force characteristics. Canberra: ABS, 1998. (Catalogue No. 2017.0)
- 23. Musharbash Y. Indigenous families and the welfare system: Two community case studies. Smith DE, editor. Canberra: Centre for Aboriginal Economic Policy Research, The Australian National University, 2000. (Research Monograph No. 17.)
- 24. Warchivker I, Tjapangati T, Wakerman J. The turmoil of Aboriginal enumeration: mobility and service population analysis on a Central Australian community. Aust N Z J Public Health 2000; 24: 4; 444-449.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.